Skip to content

Study of Cisatracurium and Sufentanil Consumption Using a Closed Loop Computer Control Infusion System

Effect of Dexmedetomidine on Cisatracurium Infusion and Sufentanil Consumption and Its Variations in Different Age Groups, Using a Closed Loop Computer Controlled System.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01785446
Enrollment
150
Registered
2013-02-07
Start date
2012-11-30
Completion date
Unknown
Last updated
2013-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Dexmedetomidine on Sufentanil Consumption., Quantitative Analysis of Cisatracurium Infusion Requirements, Sufentanil Consumption and Recovery Index in Different Age Groups., The Intraoperative Effect of Dexmedetomidine on Cisatracurium Infusion Consumption and Its Recovery Index.

Keywords

Dexmedetomidine, Cisatracurion infusion, Sufentanil, Recovery Index, Closed loop computer control system

Brief summary

The purpose of this study is to: * determine the effect of dexmedetomidine on cisatracurium infusion requirements and sufentanil consumption. * analyze the cisatracurium infusion requirements and sufentanil consumption in different age groups.

Interventions

DRUGEffect of dexmedetomidine on cisatracurium and sufentanil consumption

In this intervention we compared the cisatracurium consumption, recovery index and sufentanil consumption between P2 and D. The reason we are comparing patients in group D with P2 is that because they belong to the same age group.

DRUGConsumption of cisatracurium and sufentanil in different age groups.

For this intervention, we compared the cisatracurium consumption, refractory index and sufentanil consumption between group P1, P2 and P3.

Sponsors

Shehzaad Joomye
CollaboratorUNKNOWN
Haiyun Wang
CollaboratorUNKNOWN
Donglai Yan
CollaboratorUNKNOWN
Tianjin Medical University General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA status 1 and 2. * Consent approval written and oral. * Patients scheduled for elective abdominal surgery under general anesthesia.

Exclusion criteria

* Patients with neuromuscular disorders. * Patients with history of stroke, flaccid paralysis or other neurological disorders. * Significant renal, hepatic or cardiac dysfunction. * Consent refusal.

Design outcomes

Primary

MeasureTime frameDescription
Cisatracurium infusion consumption.At the time of surgeryMeasurements were done during the operation. Cisatracurium infusion was controlled a closed loop computer system. The degree of neuromuscular blockage was assessed every 20 seconds throughout the procedure using the train of four testing. It was done by counting the number and amplitude of twitches evoked after electrical stimulus and the rate of infusion maintained itself at the low rate of 0.20µg/kg/min as long as the T1 response is less than 1%. When the T1 \> 1%, the rate of infusion would automatically increase to 5.0 µg/kg/min until T1 \< 1%, after which the infusion rate would fall back to 0.20µg/kg/min. The controlled infusion described above administered small doses of cisatracurium intra-operatively to maintain a muscle relaxation of more than 99%. The system saved the time and amount of drug given throughout the operation, from which the consumption was calculated in µg/kg/min.

Secondary

MeasureTime frameDescription
Sufentanil consumption.At the time of operation.Analgesia was maintained by intermittent bolus dose of 10-20 µg of Sufentanil when the pulse and blood pressure would increase by more than 20% of the baseline, and BIS in the required range, as this would indicate an increase perception of pain but adequate anaesthesia. Sufentanil consumption was calculated for each patient in µg/kg/hr and the length of the operation was determined as from induction to the time of skin closure.

Other

MeasureTime frameDescription
Recovery Index30 minutes post-operative.Recovery Index, time for the Train-Of-Four (TOF) value to increase from 25% to 75%, was measured in each patient who completed the study. Its measurements were recorded in minutes.

Countries

China

Contacts

Primary ContactShehzaad Joomye, M.D.
s_joomye@hotmail.com8613072283346

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026